Published in J Biomed Mater Res A on November 01, 2004
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.63
Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm (2007) 2.25
Engineering cartilage tissue. Adv Drug Deliv Rev (2007) 2.08
Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60
Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat (2007) 1.31
Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Synthesis of oligo(poly(ethylene glycol) fumarate). Nat Protoc (2012) 1.09
Mesenchymal stem cell-based tissue engineering for chondrogenesis. J Biomed Biotechnol (2011) 0.93
Neural network analysis identifies scaffold properties necessary for in vitro chondrogenesis in elastin-like polypeptide biopolymer scaffolds. Tissue Eng Part A (2010) 0.87
A 3D hybrid model for tissue growth: the interplay between cell population and mass transport dynamics. Biophys J (2009) 0.84
Microcavitary hydrogel-mediating phase transfer cell culture for cartilage tissue engineering. Tissue Eng Part A (2010) 0.84
Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs. Adv Mater (2012) 0.84
A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects. J Mater Sci Mater Med (2011) 0.82
Multi-Functional Macromers for Hydrogel Design in Biomedical Engineering and Regenerative Medicine. Int J Mol Sci (2015) 0.76
Toughening of Thermoresponsive Arrested Networks of Elastin-Like Polypeptides To Engineer Cytocompatible Tissue Scaffolds. Biomacromolecules (2016) 0.75
Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng (2006) 4.53
Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules (2006) 3.01
Biomimetic materials for tissue engineering. Biomaterials (2003) 2.87
Strategic directions in tissue engineering. Tissue Eng (2007) 2.70
Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A (2003) 2.42
Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release (2005) 2.32
Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm (2007) 2.25
Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A (2002) 2.24
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A (2006) 2.03
Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol (2008) 2.00
Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.97
Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev (2008) 1.92
Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am (2008) 1.91
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem (2004) 1.87
Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials (2005) 1.85
Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol (2005) 1.80
Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther (2006) 1.79
Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng (2003) 1.79
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release (2005) 1.68
Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials (2007) 1.67
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
Induction of chondrogenesis from human embryonic stem cells without embryoid body formation by bone morphogenetic protein 7 and transforming growth factor beta1. Arthritis Rheum (2009) 1.64
Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials (2005) 1.63
Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A (2005) 1.61
The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol (2003) 1.61
Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60
Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res B Appl Biomater (2003) 1.59
Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J Biomed Mater Res A (2005) 1.58
Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev (2012) 1.57
Engineering complex tissues. Sci Transl Med (2012) 1.54
Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. Biomaterials (2002) 1.52
In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release (2003) 1.52
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc (2012) 1.51
Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules (2009) 1.48
Bioactive poly(L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials (2002) 1.47
Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res (2002) 1.46
Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release (2004) 1.45
Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules (2004) 1.45
Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem (2001) 1.44
Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater (2008) 1.43
Increased accumulation of superficial zone protein (SZP) in articular cartilage in response to bone morphogenetic protein-7 and growth factors. J Orthop Res (2007) 1.39
Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng Part A (2010) 1.38
Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev (2011) 1.37
In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone (2008) 1.35
Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng (2007) 1.35
Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res (2002) 1.34
Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A (2007) 1.34
Mechanotransduction of bovine articular cartilage superficial zone protein by transforming growth factor beta signaling. Arthritis Rheum (2007) 1.33
In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A (2004) 1.32
Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res (2005) 1.32
Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res (2002) 1.31
Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst. J Biomater Sci Polym Ed (2002) 1.30
Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis. Biomark Insights (2009) 1.29
Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng (2005) 1.29
In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules (2003) 1.29
The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials (2008) 1.29
Identification of superficial zone articular chondrocyte stem/progenitor cells. Biochem Biophys Res Commun (2007) 1.27
Differential regulation of lubricin/superficial zone protein by transforming growth factor beta/bone morphogenetic protein superfamily members in articular chondrocytes and synoviocytes. Arthritis Rheum (2007) 1.25
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A (2013) 1.23
Injectable nanocomposites of single-walled carbon nanotubes and biodegradable polymers for bone tissue engineering. Biomacromolecules (2006) 1.23
Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng (2006) 1.23
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer. J Biomed Mater Res (2002) 1.22
Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am (2008) 1.22
In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res (2008) 1.21
Angiogenesis with biomaterial-based drug- and cell-delivery systems. J Biomater Sci Polym Ed (2004) 1.21
Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. Acta Biomater (2010) 1.21
Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater (2009) 1.21
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A (2003) 1.20
In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials (2003) 1.19
Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B Rev (2010) 1.19
Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A (2009) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers. Biomacromolecules (2008) 1.18
Articular cartilage: structure and regeneration. Tissue Eng Part B Rev (2010) 1.17
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials (2012) 1.17
Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials (2010) 1.16
Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res (2006) 1.16
Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J Orthop Res (2006) 1.16
In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng (2006) 1.15
Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer. Cancer Res (2004) 1.15
Development of an atrophic nonunion model and comparison to a closed healing fracture in rat femur. J Orthop Res (2003) 1.14
In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials (2009) 1.13
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. Tissue Eng Part A (2010) 1.12
Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage (2005) 1.11
A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res (2008) 1.11
Two-dimensional nanostructure-reinforced biodegradable polymeric nanocomposites for bone tissue engineering. Biomacromolecules (2013) 1.11
In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials (2003) 1.11
Profiling microRNA expression in bovine articular cartilage and implications for mechanotransduction. Arthritis Rheum (2009) 1.10
Induction of chondrogenesis and expression of superficial zone protein (SZP)/lubricin by mesenchymal progenitors in the infrapatellar fat pad of the knee joint treated with TGF-beta1 and BMP-7. Biochem Biophys Res Commun (2008) 1.10
The effect of hypoxia on the chondrogenic differentiation of co-cultured articular chondrocytes and mesenchymal stem cells in scaffolds. Biomaterials (2013) 1.10